James Patrick Tursi

James Patrick Tursi, listed as board member, has filed trades across 7 companies (mainly through SEC (Form 4)), most often in Auxilium Pharmaceuticals Inc, Aralez Pharmaceuticals Inc. and Agile Therapeutics Inc. We count 45 filings; the first trade dates from 7 February 2013 and the latest from 30 June 2025.

In open-market terms, that means 3 purchases worth €58k on one side and 9 sales worth €2.4M on the other. Sales outweigh purchases by €2.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 23 share grants and 6 option exercises.

Half of the purchases are above €15k and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 1 July 2025, the filings show a share grant in MetaVia Inc. The last purchase on record was published on 17 March 2017, which is 3,507 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.